BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26302425)

  • 1. Do Palliative Care Clinics Screen for Substance Abuse and Diversion? Results of a National Survey.
    Tan PD; Barclay JS; Blackhall LJ
    J Palliat Med; 2015 Sep; 18(9):752-7. PubMed ID: 26302425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for substance abuse and diversion in Virginia hospices.
    Blackhall LJ; Alfson ED; Barclay JS
    J Palliat Med; 2013 Mar; 16(3):237-42. PubMed ID: 23289944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and Assessment of Substance Use in Hospice Care: Examining Content from a National Sample of Psychosocial Assessments.
    Sacco P; Cagle JG; Moreland ML; Camlin EAS
    J Palliat Med; 2017 Aug; 20(8):850-856. PubMed ID: 28333571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse: a national survey of Canadian residency program directors and site chiefs at university-affiliated anesthesia departments.
    Boulis S; Khanduja PK; Downey K; Friedman Z
    Can J Anaesth; 2015 Sep; 62(9):964-71. PubMed ID: 26001750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic.
    Rauenzahn S; Sima A; Cassel B; Noreika D; Gomez TH; Ryan L; Wolf CE; Legakis L; Del Fabbro E
    Support Care Cancer; 2017 Jun; 25(6):1859-1864. PubMed ID: 28120116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and Chronic Pain in Cancer Survivors: Evolving Practice for Palliative Care Clinics.
    Chwistek M; Ewerth N
    J Palliat Med; 2016 Mar; 19(3):254. PubMed ID: 26788763
    [No Abstract]   [Full Text] [Related]  

  • 8. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse attitudes and policies in US rehabilitation training programs: a comparison of 1985 and 2000.
    Basford JR; Rohe DE; Barnes CP; DePompolo RW
    Arch Phys Med Rehabil; 2002 Apr; 83(4):517-22. PubMed ID: 11932854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen.
    Barclay JS; Owens JE; Blackhall LJ
    Support Care Cancer; 2014 Jul; 22(7):1883-8. PubMed ID: 24563103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirituality training for palliative care fellows.
    Marr L; Billings JA; Weissman DE
    J Palliat Med; 2007 Feb; 10(1):169-77. PubMed ID: 17298265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Training of palliative medicine fellows: a report from the field.
    Carmody S; Meier D; Billings JA; Weissman DE; Arnold RM
    J Palliat Med; 2005 Oct; 8(5):1005-15. PubMed ID: 16238513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Testing Incoming Residents and Medical Students in Family Medicine Training: A Survey of Program Policies and Practices.
    Bell PF; Semelka MW; Bigdeli L
    J Grad Med Educ; 2015 Mar; 7(1):59-64. PubMed ID: 26217424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of objective data to identify risk for medication misuse and abuse: the inconsistency score.
    Hamill-Ruth RJ; Larriviere K; McMasters MG
    Pain Med; 2013 Dec; 14(12):1900-7. PubMed ID: 23947737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accreditation Council for Graduate Medical Education accreditation and influence on perceptions of pediatric otolaryngology fellowship training experience.
    Bedwell JR; Choi S; Chan K; Preciado D
    JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):890-4. PubMed ID: 23948953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.